2 de diciembre de 2014 / 9:04 / hace 3 años

REFILE-Avanir to be bought by Japan's Otsuka Pharmaceutical for $3.5 bln

(Adds dropped word ‘said’ in paragraph 1)

Dec 2 (Reuters) - Avanir Pharmaceuticals Inc said it agreed to be acquired by a unit of Japan’s Otsuka Holdings Co Ltd for about $3.5 billion.

Otsuka Pharmaceutical Co Ltd will pay $17 per share in cash, representing a premium of 13.3 percent to Avanir’s stock close on Monday. (Reporting by Neha Dimri in Bengaluru; Editing by Gopakumar Warrier)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below